“…The first percutaneous bone conduction device with an abutment applying the principle of osseointegration was described more than three decades ago ( Tjellstrom & Granstrom, 1994 ; Tjellstrom, Lindstrom, Hallen, Albrektsson, & Branemark, 1981 ) and the Bone-anchored hearing aid (Baha) percutaneous device on an osseointegrated post is currently the most widely distributed bone conduction device so far ( Snik et al., 2005 ). Two devices are commercially available at present, Baha (Cochlear Bone Anchored Solutions, Mölnlycke, Sweden; ( Bento, Kiesewetter, Ikari, & Brito, 2012 ; Boleas-Aguirre, Bulnes Plano, de Erenchun Lasa, & Ibanez Beroiz, 2012 ; Dun, Faber, de Wolf, Cremers, & Hol, 2011 ; Lustig et al., 2001 ) and Ponto (Oticon, Smørum, Denmark; Westerkull, 2011 ). However, certain drawbacks are inherent to the principle of a percutaneous device.…”